Approval · Notice of Compliance 16410 · 2014
SOVALDI: Notice of Compliance 16410
Issued December 5, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16410
- Date
- December 5, 2014
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOVALDI | Not yet assigned | — |
Medicinal ingredients
- SOFOSBUVIR 400 MG per TAB